These innovative medications, like copyright and Semaglutide, represent a significant class of drugs called GLP-1 receptor mimics. These drugs work by stimulating the body's own ability to secrete GLP-1, a hormone that helps control blood sugar and appetite. Initially, created for treating type 2 diabetes, these medications have also shown promise

Patients struggling with obesity are often faced with limited and sometimes ineffective treatment options. However, a groundbreaking new medication, Wegovy, is rapidly changing the landscape of weight loss. Utilized by regulatory bodies for chronic weight management, Semaglutide acts as a glucagon-like peptide-1 (GLP-1) receptor agonist. This mech